Mawi DNA Technologies (Mawi DNA), a biotechnology company focusing on the development and design of innovative technologies for biosampling, announces that the U.S. Food and Drug Administration (FDA)
Ancora Heart Inc and egnite, Inc Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Ancora Heart Appoints Mark Miles as Chief Commercial Officer · BioBuzz
biobuzz.io - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biobuzz.io Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Ancora Heart Enrolls First Patient in the CORCINCH-HF Study
January 28, 2021 GMT
As the only completely transcatheter procedure to treat the enlarged left ventricle, the AccuCinch® Ventricular Restoration System is a fundamentally different and innovative device-based therapy designed to improve the structure and function of the heart and help bring relief to HF patients who remain symptomatic despite current guideline-directed medical care. (Graphic: Business Wire)
As the only completely transcatheter procedure to treat the enlarged left ventricle, the AccuCinch® Ventricular Restoration System is a fundamentally different and innovative device-based therapy designed to improve the structure and function of the heart and help bring relief to HF patients who remain symptomatic despite current guideline-directed medical care. (Graphic: Business Wire)